Vagus Nerve Stimulation Therapy News 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.FDA Okays VNS for Epilepsy in Children as Young as 4 Years FDA Okays VNS for Epilepsy in Children as Young as 4 Years
VNS therapy is indicated as an adjunctive therapy to reduce the frequency of seizures in children with partial-onset seizures refractory to antiepileptic medications.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 30, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news
LivaNova wins FDA nod for VNS therapy neurostim for young epilepsy patients
LivaNova (NSDQ:LIVN) said today it won FDA approval of its Vagus Nerve Stimulation Therapy system for patients as young as 4 years of age with partial onset seizures that are refractory to antiepileptic medications.
The London-based company touted that with the clearance, its VNS Therapy system is the only FDA-approved device for drug-resistant epilepsy in the pediatric population. Previously, the device was only approved for patients ages 12 and older.
“Epilepsy affects one in 26 Americans, and 35% of these patients fail to respond to medications. VNS Therapy offers many of these patients a chance for improved sei...
Source: Mass Device - June 29, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance LivaNova Source Type: news
Medical News Today: What is the vagus nerve?
In this article, learn about the vagus nerve and what it affects in the body. What is vagus nerve stimulation and what further research is being conducted? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 28, 2017 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news
LivaNova wins expanded MR indication for VNS Therapy device
LivaNova (NSDQ:LIVN) said today it won FDA approval for expanded MRI labeling for its Vagus Nerve Stimulation Therapy device, touting it as the only epilepsy device cleared by the FDA for MRI scans.
With the approval, patients with the minimally invasive VNS system are cleared to visit any MRI center in the US, with access to more than 90% of routine scans for patients with epilepsy, the London-based company said.
“The FDA’s approval to expand our MRI labeling changes the landscape for device-based epilepsy therapies. This further differentiates our technology from other epilepsy treatment options and adds a new d...
Source: Mass Device - June 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Source Type: news
ElectroCore touts gammaCore cluster headache trial data
Neuroscience tech developer ElectroCore today released data from the ACT clinical trials exploring the use of its gammaCore non-invasive vagus nerve stimulator for treating patients with episodic cluster headaches.
Results from the study were presented at the 59th Annual Scientific Meeting of the American Headache Society, the company said.
The 250-patient studies evaluated the safety and efficacy of the gammaCore device as an acute treatment for patients with cluster headaches, the company said. Data from the trial indicated that the proportion for patients who achieved mild or no pain at 15 minutes post treatment was...
Source: Mass Device - June 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Pain Management electroCore Source Type: news
Here ’s how vagus nerve stimulation is getting better
A vagus nerve implant with 2 electrodes – one to apply desired stimulation going down into the body, the other to block unwanted stimulation going up to the brain. [Image from Georgia Tech/Rob Felt]Georgia Institute of Technology researchers have reported success targeting vagus nerve stimulation – providing hope for people with a host of inflammatory diseases including rheumatoid arthritis, irritable bowel syndrome and Crohn’s disease.
Researchers implanted a pacemaker-like device into rats and showed that it could electrically stimulate the vagus nerve while simultaneously preventing unwanted nerve activity. By add...
Source: Mass Device - June 8, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Implants Research & Development Georgia Institute of Technology MedTech stimulation vagus nerve Source Type: news
FDA Approves Vagus Stimulation Device for Cluster Headache FDA Approves Vagus Stimulation Device for Cluster Headache
The FDA has approved a noninvasive vagus nerve stimulation device for the treatment of pain from cluster headache in adults.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 18, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
FDA clears ElectroCore ’ s GammaCore cluster headache treatment
Neuroscience tech developer ElectroCore said today it won FDA clearance for its GammaCore non-invasive vagus nerve stimulator designed to treat pain associated with episodic cluster headaches.
The GammaCore device is designed to transmit a mild electrical stimulation to the vagus nerve through the skin to reduce pain, the Basking Ridge, N.J.-based company said. The device is the company’s 1st to win FDA clearance.
“The U.S. release of gammaCore for the acute treatment of pain associated with episodic cluster headache in adult patients is a major milestone for electroCore, as it not only marks electroCoreR...
Source: Mass Device - April 18, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Pain Management Regulatory/Compliance electroCore Source Type: news
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
First U.S. Food and Drug Administration (FDA) release for electroCore, a neuroscience and technology company
Hand-held, non-invasive, easy-to-use device provides new option for the approximately 400,000 Americans living with this rare but extremely debi... Devices, FDA electroCore, gammaCore, vagus nerve stimulation, cluster headache (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 18, 2017 Category: Pharmaceuticals Source Type: news
Potential way to reduce drug cravings: Vagus nerve stimulation therapy
A new preclinical study shows that vagus nerve stimulation therapy might have the potential to help people overcome drug addiction by helping them learn new behaviors to replace those associated with seeking drugs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 23, 2017 Category: Science Source Type: news
Researcher finds potential way to reduce drug cravings
(University of Texas at Dallas) A new preclinical study led by a University of Texas at Dallas researcher shows that vagus nerve stimulation therapy might have the potential to help people overcome drug addiction by helping them learn new behaviors to replace those associated with seeking drugs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2017 Category: Global & Universal Source Type: news
Buzzing the vagus nerve just right to fight inflammatory disease
Electrical vagus nerve stimulation can help fight inflammatory diseases like Crohn ' s or arthritis but can also contribute somewhat to inflammation. Engineers have tweaked the buzz to keep the good effects and minimize those less desirable. Their innovation could be adapted to existing medical devices with relative ease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 5, 2017 Category: Science Source Type: news
Buzzing the vagus nerve just right to fight inflammatory disease
(Georgia Institute of Technology) Electrical vagus nerve stimulation can help fight inflammatory diseases like Crohn's or arthritis but can also contribute somewhat to inflammation. Engineers have tweaked the buzz to keep the good effects and minimize those less desirable. Their innovation could be adapted to existing medical devices with relative ease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 5, 2017 Category: Global & Universal Source Type: news
LivaNova shares tumble on CEO exit, Q3 earnings report
LivaNova (NSDQ:LIVN) shares slid nearly 15% today after the company announced the resignation of CEO André-Michel Ballester and released its 3rd quarter earnings.
The London-based company said its current CEO Ballester will resign effective December 31 this year, to be replaced by current COO Damien McDonald.
Ballester served as CEO at Sorin from 2007 to 2015, up to the merger that created LivaNova when the company joined with Cyberonics, the company said.
“On behalf of the LivaNova board of directors, I would like to thank André-Michel for his highly successful 12-year career with LivaNova and Sorin. André-Miche...
Source: Mass Device - November 2, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News LivaNova Source Type: news
Effects of brisk walking on autonomic nervous system reactivation in nursing home residents. Additional effects of transcutaneous vagus nerve stimulation - Raffin J, Barth élémy JC, Terrat P, Diana MC, Achour É, Calmels P, Oriol M, Busso T, Hammadi L, Montuy-Coquard C, Bouvier R, Poillerat R, Roche F, Hupin D.
OBJECTIVE: It is well established that physical activity reduces the physiological effects of ageing. Among them, is the decrease of the autonomic nervous system (ANS) activity, which is associated with the increase of cardiovascular events and morbidities... (Source: SafetyLit)
Source: SafetyLit - October 1, 2016 Category: Global & Universal Tags: Age: Elder Adults Source Type: news
